» Articles » PMID: 31669695

Synthesis, Characterization, DNA/BSA Interactions and in Vitro Cytotoxicity Study of Palladium(II) Complexes of Hispolon Derivatives

Overview
Journal J Inorg Biochem
Specialty Biochemistry
Date 2019 Nov 1
PMID 31669695
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Thirteen novel palladium(II) complexes of the general formula [Pd(bipy)(O,O'-dkt)](PF), (where bipy is 2,2'-bipyridine and O,O'-dkt is β-diketonate ligand hispolon or its derivative) have been prepared through a metal-ligand coordination method that involves spontaneous formation of the corresponding diketonate scaffold. The obtained palladium(II) complexes have been characterized by NMR spectroscopy, ESI-mass spectrometry as well as elemental analysis. The cytotoxicity analysis indicates that most of the obtained palladium(II) complexes show promising growth inhibition in three human cancer cell lines. Flow cytometry analysis shows complex 3e could promote intracellular reactive oxygen species (ROS) accumulation and lead cancer cell death. And the suppression of ROS accumulation and the rescue of cell viability in HeLa cells by N-acetyl-L-cysteine (NAC) suggest the possible link between the increase in ROS generation and cytotoxicity of complex 3e. Flow cytometry analysis also reveal that complex 3e cause cell cycle arrest in the G2/M phase and collapse of the mitochondrial membrane potential, promote the generation of ROS and lead to tumor cell apoptosis. The interactions of complex 3e with calf thymus DNA (CT-DNA) have been evaluated by UV-Vis spectroscopy, fluorescence quenching experiments and viscosity measurements, which reveal that the complex interact with CT-DNA through minor groove binding and/or electrostatic interactions. Further, the results of fluorescence titration and site marker competitive experiment on bovine serum albumin (BSA) suggest that complex 3e can quench the fluorescence of BSA via a static quenching process and bind to BSA in Sudlow's site II.

Citing Articles

Plausible PEPPSI catalysts for direct C-H functionalization of five-membered heterocyclic bioactive motifs: synthesis, spectral, X-ray crystallographic characterizations and catalytic activity.

Bensalah D, Mansour L, Sauthier M, Gurbuz N, Ozdemir I, Beji L RSC Adv. 2023; 13(45):31386-31410.

PMID: 37941793 PMC: 10628855. DOI: 10.1039/d3ra06334h.


Electronic and ring size effects of N-heterocyclic carbenes on the kinetics of ligand substitution reactions and DNA/protein interactions of their palladium(II) complexes.

Omondi R, Jaganyi D, Ojwach S Biometals. 2023; 36(5):1109-1123.

PMID: 37184626 PMC: 10545578. DOI: 10.1007/s10534-023-00507-8.


Synthesis, substitution kinetics, DNA/BSA binding and cytotoxicity of tridentate N^E^N (E = NH, O, S) pyrazolyl palladium(II) complexes.

Omondi R, Fadaka A, Fatokun A, Jaganyi D, Ojwach S J Biol Inorg Chem. 2022; 27(7):653-664.

PMID: 36197522 DOI: 10.1007/s00775-022-01959-y.


Palladium(II) Complexes of Substituted Salicylaldehydes: Synthesis, Characterization and Investigation of Their Biological Profile.

Zianna A, Geromichalos G, Fiotaki A, Hatzidimitriou A, Kalogiannis S, Psomas G Pharmaceuticals (Basel). 2022; 15(7).

PMID: 35890184 PMC: 9323974. DOI: 10.3390/ph15070886.


Lysosomal Targeted Cyclometallic Iridium(Ⅲ) Salicylaldehyde-Coumarin Schiff Base Complexes and Anticancer Application.

Xu R, Wu Y, Liu Z, Liu J, Liu X Front Chem. 2022; 10:906954.

PMID: 35620650 PMC: 9127163. DOI: 10.3389/fchem.2022.906954.